Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT06161844 · COMPLETED

Trial details

NCT number: NCT06161844
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2024-02-23
Primary completion: 2025-05-14
Enrollment: 506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.